maritide glp 1 Trial Scorecard: Amgen's Maritide Shows Significant Weight
Description
In obesity, Novos Wegovy (semaglutide injection) was approved in 2021, however uptake has been hindered by access limitations, with no Medicare coverage and limited coverage among commercial plans
Researchers are still learning about their other potential uses
In a separate study, daily cotadutide administration for 41 days reduced fasting glucose and HbA1c and decreased liver fat and volume
PMCID: PMC8478295
After clinician review: A prescription may be issued only if a licensed clinician determines prescribing is appropriate, and Willow does not present this as automatic
